Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial ....

BIOGEN PHARMACHEM INDUSTRIES LIMITED CIN NO: L51100GJ1995PLC026702 (Formerly Known as SUN TECHNO OVERSEAS LIMITED) Date:04.09.2026 Department of Corporate Services BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Ref: Scrip Code: 531752 Scrip ID: BIOGEN Dear Sir/Madam, Sub: Submission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2025-26 along with the Notice of Annual General Meeting to be held on Tuesday 29th of September 2026. Thanking you. Yours Faithfully, FOR, BIOGEN PHARMACHEM INDUSTRIES LIMITED KELASH BUNKAR Director Encl.: As above. Registered Office Address: Shop No. 8, First Floor, Makers – 1 Building, Jawahar Road, Rajkot-360001 E mail biogenpharmachem@gmail.com 31ST ANNUAL REPORT 2025-26 of BIOGEN PHARMACHEM INDUSTRIES LIMITED BOARD OF DIRECTOR CHANDRAKANT GOVINDBHAI PARMAR DIRECTOR KELASH BUNKAR WHOLETIME DIRECTOR & CHIEF FINANCIAL OFFICER CHHAYABEN PARMAR DIRECTOR NARENDRAKUMAR VANIYA DIRECTOR AMAN PATEL DIRECTOR HARSHADKUMAR RATHOD DIRECTOR KHUSHBOO KHANDELWAL COMPANY SECRETARY Auditor M/S. GOENKA MEHTA & ASSOCIATES CHARTERED ACCOUNTANTS RAJKOT SHARE TRANSFER AGENT M/s SATELLITE CORPORATE SERVICES PRIVATE LIMITED Office No 106-107, Dattani Plaza, East West Compound, Andheri Kurla Road, Safedpul Sakinaka,Mumbai,Maharashtra,400072 Ph No: +91-22-2852 0461 / 2852 0462 Fax No: +91-22-2851 1809 E mail: service@satellitecorporate.com REGISTERED OFFICE SHOP NO 8, FIRST FLOOR, MAKERS - 1 BUILDING JAWAHAR ROAD,RAJKOT GJ 360001 INDEX Contents Page No. Notice of Annual General Meeting 1 Director Report 9 MANAGEMENT DISCUSSION ANALYSIS REPORT 14 Form No. MR-3 - SECRETARIAL AUDIT REPORT 15 Corporate Governance Report 19 Auditors’ Report 30 Balance Sheet 42 Profit and Loss Account 43 Cash Flow Statement 44 Notes forming part of the financial statements 46 BIOGEN PHARMACHEM INDUSTRIES LIMITED CIN: L51100GJ1995PLC026702 N O T I C E NOTICE is hereby given that the 31ST ANNUAL GENERAL MEETING of the Members of BIOGEN PHARMACHEM INDUSTRIES LIMITED (Formerly known as SUN TECHNO OVERSEAS LIMITED) will be held on Tuesday, 29th September,2026 at 04:00 P.M. through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) to transact the following business: ORDINARY BUSINESS: 1. To receive, consider and adopt the audited financial statements of the Company for the financial year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereon. 2. To appoint a Director in place of Mr. Kelash Bunkar (DIN: 10911360) who retires by rotation and being eligible, offers him-self for re-appointment. 3. To reappoint statutory auditors and fix their remuneration and in this regard to consider and if thought fit, to pass, with or without modification(s), the following Resolution as an Ordinary Resolution: RESOLVED THAT subject to the provisions of Sections 139, 142 and any other applicable provisions, if any, of the Companies Act, 2013 (“the Act”), and Companies (Audit and Auditors) Rules 2014, ( including any statutory modification(s) or re-enactment thereof for the time being in force), M/s. Goenka Mehta & Associates Chartered Accountants, Rajkot (Firm Registration No: 129445W) retiring statutory auditor be and are hereby reappointed as the Statutory Auditors of the Company to hold office from the conclusion of this Annual General Meeting to Annual General Meeting held in 2031 and at such remuneration as may be fixed by the Board of Directors of the Company on the recommendation of the Audit Committee RESOLVED FURTHER THAT the Board of directors of the company (including any Committee thereof) be and is hereby authorized to do all such acts and take all such steps as maybe necessary, proper or expedient to give effect to this resolution. Notes: 1. Pursuant to the Circular No 14/2020, 17/2020, 20/2020, 02/2021, 19/2021, 21/2021, 02/2022, 10/2022 and 9/2023 dated 8th April 2020, 13th April 2020, 5th May 2020, 13th January 2021, 8th December 2021, 14th December 2021, 5th May 2022, 28th December 2022 and 25th September 2023, respectively, (“MCA Circulars”) and Securities and Exchange Board of India vide its circular dated 7th October 2023 read with 12th May, 2020, 15th January 2021, 13th May 2022 and 5th January 2023 ("SEBI Circular"), General Circular 09/2023 dated 25.09.2023 and General Circular No.09/2024 dated 19.09.2024 after due examination General Circular 09/2025 dated 22.09.2025 permitted the holding of the Annual General Meeting (“AGM”) through VC / OAVM, without the physical presence of the Members at a common venue. In compliance with the provisions of the Companies Act, 2013 (“Act”), Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) and MCA Circulars, the AGM of the Company will be held through VC / OAVM. Hence, Members can attend and participate in the AGM through VC/OAVM only. The deemed venue for the AGM of the Company shall be the Registered Office of the Company. The detailed procedure for participating in the meeting through VC/OAVM is explained in the subsequent notes of this Notice. Page 1 31ST ANNUAL REPORT 2025-26 BIOGEN PHARMACHEM INDUSTRIES LIMITED CIN: L51100GJ1995PLC026702 2. Pursuant to the provisions of the Act, a Member entitled to attend and vote at the AGM is entitled to appoint a proxy to attend and vote on his/her behalf and the proxy need not be a Member of the Company. Since this AGM is being held pursuant to the MCA Circulars through VC / OAVM, physical attendance of Members has been dispensed with. Accordingly, the facility for appointment of proxies by the Members will not be available for the AGM and hence the Proxy Form and Attendance Slip are not annexed to this Notice. 3. Institutional / Corporate Shareholders (i.e. other than individuals / HUF, NRI, etc.) are required to send a scanned copy (PDF/JPG Format) of its Board or governing body Resolution/Authorization etc., authorizing its representative to attend the AGM through VC / OAVM on its behalf and to vote through remote e-voting. The said Resolution/Authorization shall be sent to the Scrutinizer by email through its registered email address. 4. The Register of Members and Share Transfer Register of the Company will remain closed from 22nd September, 2026 to 29th September, 2026 (both days inclusive). 5. Members are requested to send their queries to the Company, if any, on accounts and operations of the Company at least ten days before the meeting so that the same could be suitably answered at the meeting. 6. Members whose shareholding(s) are in electronic mode are requested to inform any changes relating to address, bank mandate and Electronic Clearing Services (ECS) details to their respective Depository Participants and in case of physical shares, to the Company's Registrar & Share Transfer Agent M/s. Satellite Corporate Services Private Limited by mail at service@satellitecorporate.com together with a valid proof of address. 7. As per Regulation 40 of SEBI Listing Regulations, as amended, securities of listed companies can be transferred only in dematerialized form with effect from, April 1, 2019, except in case of request received for transmission or transposition of securities. In view of this and to eliminate all risks associated with physical shares and for ease of portfolio management, members holding shares in physical form are requested to consider converting their holdings to dematerialized form. Members can contact the Company or Company’s Registrars and Transfer Agents, for assistance in this regard. 8. In line with measures of Green Initiative taken by the Ministry of Corporate Affairs (vide circular nos. 17/2011 and 18/2011 dated April 21 and April 29, 2011 respectively) and Companies Act, 2013 also provides for sending notice of the me [Showing first 8,000 characters — download PDF for full document]